SCHEMBL22097022

SCHEMBL22097022

c1ccc(-c2nc(-c3ccc4c(c3)c3ccccc3c3ccc5oc6ccccc6c5c34)nc3ccc4ccccc4c23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ABCG2 Q9UNQ0 5/20 0.38
PAX8 Q06710 2/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1A2 P05177 1/20 0.38
FYN P06241 1/20 0.38
MAPK3 P27361 1/20 0.38
AHR P35869 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ATM Q13315 1/20 0.37
MAPT P10636 6/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
RECQL P46063 1/20 0.36
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22096957 0.95 MAPT (0.40) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL22880130 0.91 ABCG2 (0.41) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL22879830 0.90 TDP1 (0.41) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL22096955 0.89 MEN1 (0.36) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL22097153 0.89 KMT2A (0.37) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL22249906 0.89 ABCG2 (0.40) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL22097170 0.87 MEN1 (0.48) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL22097014 0.87 ATM (0.39) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL19758360 0.87 PLA2G2A (0.41) L3MBTL1ABCG2CYP1A2AHRMEN1
SCHEMBL22096984 0.87 MEN1 (0.50) L3MBTL1MEN1KMT2AATMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 TDP1 3684/4885L3MBTL1 179/4885ABCG2 1273/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 TDP1 3684/4885L3MBTL1 179/4885ABCG2 1273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.